Michael C. Barnes https://michaelcbarnes.com Attorney & Policy Advisor Tue, 28 May 2024 20:46:06 +0000 en hourly 1 Why Congress and the FDA Must Regulate CBD Consumer Products Now https://michaelcbarnes.com/why-congress-and-the-fda-must-regulate-cbd-consumer-products-now/ Wed, 03 Jan 2024 21:39:19 +0000 https://michaelcbarnes.com/?p=1948 The CBD consumer product market is largely unregulated. Consumers have no way to be sure that the product they buy contains the ingredients listed on the label, and that it does not contain intoxicants or contaminants. Full story

The post Why Congress and the FDA Must Regulate CBD Consumer Products Now appeared first on Michael C. Barnes.

]]> The CBD consumer product market is largely unregulated. Consumers have no way to be sure that the product they buy contains the ingredients listed on the label, and that it does not contain intoxicants or contaminants.

Full story

The post Why Congress and the FDA Must Regulate CBD Consumer Products Now appeared first on Michael C. Barnes.

]]> Journal Publishes Special Edition on Regulatory Responses to Opioid Poisoning Crisis https://michaelcbarnes.com/journal-publishes-special-edition-on-regulatory-responses-to-opioid-poisoning-crisis/ Wed, 01 Nov 2023 20:42:37 +0000 https://michaelcbarnes.com/?p=1947 The Journal of Opioid Management (JOM) has published a special edition addressing legal and policy responses to the intertwined challenges of inadequate pain management and opioid misuse. Michael C. Barnes, Esq., Chairman of the Center for U.S. Policy, served as JOM’s Special Issue Editor. Full story

The post Journal Publishes Special Edition on Regulatory Responses to Opioid Poisoning Crisis appeared first on Michael C. Barnes.

]]> The Journal of Opioid Management (JOM) has published a special edition addressing legal and policy responses to the intertwined challenges of inadequate pain management and opioid misuse. Michael C. Barnes, Esq., Chairman of the Center for U.S. Policy, served as JOM’s Special Issue Editor.

Full story

The post Journal Publishes Special Edition on Regulatory Responses to Opioid Poisoning Crisis appeared first on Michael C. Barnes.

]]> What You Need to Know about Cannabinoid Law and Science https://michaelcbarnes.com/what-you-need-to-know-about-cannabinoid-law-and-science/ Thu, 05 Jan 2023 21:34:44 +0000 https://michaelcbarnes.com/?p=1946 We, as consumers, need to be aware of the laws surrounding marijuana, CBD, and other cannabinoid products. Understanding these laws will allow us to make informed decisions based on the legality of cannabinoid products, and what we know about their safety. Full story

The post What You Need to Know about Cannabinoid Law and Science appeared first on Michael C. Barnes.

]]> We, as consumers, need to be aware of the laws surrounding marijuana, CBD, and other cannabinoid products. Understanding these laws will allow us to make informed decisions based on the legality of cannabinoid products, and what we know about their safety.

Full story

The post What You Need to Know about Cannabinoid Law and Science appeared first on Michael C. Barnes.

]]> There Is Another Drug Reform Bill the Senate Must Pass https://michaelcbarnes.com/there-is-another-drug-reform-bill-the-senate-must-pass/ Thu, 15 Dec 2022 04:01:42 +0000 https://michaelcbarnes.com/?p=1922 S.3257 would facilitate access to treatment for opioid use disorder, which is essential amid the nationwide fentanyl poisoning crisis. Full story

The post There Is Another Drug Reform Bill the Senate Must Pass appeared first on Michael C. Barnes.

]]> S.3257 would facilitate access to treatment for opioid use disorder, which is essential amid the nationwide fentanyl poisoning crisis.

Full story

The post There Is Another Drug Reform Bill the Senate Must Pass appeared first on Michael C. Barnes.

]]> Finding Policy Consensus https://michaelcbarnes.com/finding-policy-consensus/ Wed, 16 Nov 2022 04:09:45 +0000 https://michaelcbarnes.com/?p=1924 Leader’s Edge sat down with Michael Barnes to discuss everything from prescription drug transparency and mental health parity to employer liability related to non-FDA-approved cannabinoids. Full story

The post Finding Policy Consensus appeared first on Michael C. Barnes.

]]> Leader’s Edge sat down with Michael Barnes to discuss everything from prescription drug transparency and mental health parity to employer liability related to non-FDA-approved cannabinoids.

Full story

The post Finding Policy Consensus appeared first on Michael C. Barnes.

]]> CUSP Files Amicus Brief in Ruan Supreme Court Case https://michaelcbarnes.com/cusp-files-amicus-brief-in-ruan-supreme-court-case/ Fri, 07 Jan 2022 16:31:24 +0000 https://michaelcbarnes.com/?p=1897 January 7, 2022 The not-for-profit Center for U.S. Policy (CUSP), together with Lynn R. Webster, M.D.; Stephen J. Ziegler, Ph.D., J.D.; and Michael C. Barnes, Esq., has filed an amicus brief asking the U.S. Supreme Court to overturn the drug trafficking conviction of a physician who did not intend to prescribe unlawfully. Full story

The post CUSP Files Amicus Brief in Ruan Supreme Court Case appeared first on Michael C. Barnes.

]]> January 7, 2022

The not-for-profit Center for U.S. Policy (CUSP), together with Lynn R. Webster, M.D.; Stephen J. Ziegler, Ph.D., J.D.; and Michael C. Barnes, Esq., has filed an amicus brief asking the U.S. Supreme Court to overturn the drug trafficking conviction of a physician who did not intend to prescribe unlawfully.

Full story

The post CUSP Files Amicus Brief in Ruan Supreme Court Case appeared first on Michael C. Barnes.

]]> Feds Warn of Scammers Impersonating DEA Agents https://michaelcbarnes.com/feds-warn-of-scammers-impersonating-dea-agents/ Wed, 05 Aug 2020 12:36:03 +0000 https://michaelcbarnes.com/?p=1847 The U.S. Drug Enforcement Agency (DEA) warns doctors, pharmacists, and the public about criminals posing as DEA agents and attempting to extort money from them. Michael C. Barnes cautions that the scammers have enough knowledge of the tactics DEA is employing against controlled-medication prescribers to be able to replicate them in other situations. Full story

The post Feds Warn of Scammers Impersonating DEA Agents appeared first on Michael C. Barnes.

]]> The U.S. Drug Enforcement Agency (DEA) warns doctors, pharmacists, and the public about criminals posing as DEA agents and attempting to extort money from them. Michael C. Barnes cautions that the scammers have enough knowledge of the tactics DEA is employing against controlled-medication prescribers to be able to replicate them in other situations.

Full story

The post Feds Warn of Scammers Impersonating DEA Agents appeared first on Michael C. Barnes.

]]> Experts Side with DEA on Opioid Quota Issue https://michaelcbarnes.com/experts-side-with-dea-on-opioid-quota-issue/ Mon, 20 Jan 2020 21:11:48 +0000 https://michaelcbarnes.com/?p=1828 Policymakers have been calling for the Drug Enforcement Administration (DEA) to reduce the number of opioids produced each year. Policy Manager Christopher Piemonte writes that experts in policy, pain, and law enforcement are all aligned in their belief that this strategy will be ineffective and that to continue to suggest it indicates a lack of […]

The post Experts Side with DEA on Opioid Quota Issue appeared first on Michael C. Barnes.

]]> Policymakers have been calling for the Drug Enforcement Administration (DEA) to reduce the number of opioids produced each year. Policy Manager Christopher Piemonte writes that experts in policy, pain, and law enforcement are all aligned in their belief that this strategy will be ineffective and that to continue to suggest it indicates a lack of education on the part of the policymakers.

Full story

The post Experts Side with DEA on Opioid Quota Issue appeared first on Michael C. Barnes.

]]> Big Business, Congress Focus on Drugs https://michaelcbarnes.com/the-opioid-crisis-and-congress-drug-pricing-bill/ Thu, 12 Dec 2019 23:17:44 +0000 https://michaelcbarnes.com/?p=1805 Michael C. Barnes discusses a major U.S. retailer’s theory that a rise in thefts may be attributed to the drug abuse crisis. He also discusses the proposed drug pricing bill before Congress.

The post Big Business, Congress Focus on Drugs appeared first on Michael C. Barnes.

]]> Michael C. Barnes discusses a major U.S. retailer’s theory that a rise in thefts may be attributed to the drug abuse crisis. He also discusses the proposed drug pricing bill before Congress.

The post Big Business, Congress Focus on Drugs appeared first on Michael C. Barnes.

]]> Pain Doctor on DOJ Settlement: ‘It Was Extortion’ https://michaelcbarnes.com/pain-doctor-on-doj-settlement-it-was-extortion/ Wed, 23 Oct 2019 13:11:48 +0000 https://michaelcbarnes.com/?p=1791 Michael C. Barnes discusses DOJ’s treatment of controlled-medication prescribers in the current climate. “Detailed medical records are the only affordable way for a provider to prove his innocence — or at least make the prosecutor think twice about proceeding with criminal charges.” Full story

The post Pain Doctor on DOJ Settlement: ‘It Was Extortion’ appeared first on Michael C. Barnes.

]]> Michael C. Barnes discusses DOJ’s treatment of controlled-medication prescribers in the current climate. “Detailed medical records are the only affordable way for a provider to prove his innocence — or at least make the prosecutor think twice about proceeding with criminal charges.”

Full story

The post Pain Doctor on DOJ Settlement: ‘It Was Extortion’ appeared first on Michael C. Barnes.

]]>